Fusion Pharmaceuticals Inc (FUSN)
21.50
+0.04
(+0.19%)
USD |
NASDAQ |
May 17, 16:00
21.50
0.00 (0.00%)
After-Hours: 20:00
Fusion Pharmaceuticals Stock Buybacks (Quarterly): -48.47M for March 31, 2024
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -48.47M |
| December 31, 2023 | -57.27M |
| September 30, 2023 | -0.045M |
| June 30, 2023 | -24.44M |
| March 31, 2023 | -63.37M |
| December 31, 2022 | -0.132M |
| September 30, 2022 | -3.981M |
| June 30, 2022 | -0.074M |
| March 31, 2022 | -1.627M |
| December 31, 2021 | 0.00 |
| Date | Value |
|---|---|
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | -197.62M |
| March 31, 2020 | |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-197.62M
Minimum
Jun 2020
--
Maximum
Jun 2019
-20.90M
Average
-0.045M
Median
Sep 2023
Stock Buybacks (Quarterly) Benchmarks
| AstraZeneca PLC | -6.00M |
| Landos Biopharma Inc | 0.00 |
| Perspective Therapeutics Inc | -53.27M |
| Acasti Pharma Inc | 0.00 |
| Aurinia Pharmaceuticals Inc | -- |